What are the recommended dosages of ipatropium bromide and albuterol for a 22-month-old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dosing for Ipratropium Bromide and Albuterol in a 22-Month-Old

For a 22-month-old child with acute asthma exacerbation, administer ipratropium bromide 100-125 mcg (half the standard pediatric dose) via nebulizer combined with albuterol, given every 20 minutes for 3 doses, then every 6 hours as needed until improvement begins. 1

Ipratropium Bromide Dosing

Age-Appropriate Dose Reduction

  • Use half doses of approximately 100-125 mcg via nebulizer for very young children under 2-3 years of age, as specifically recommended by the British Thoracic Society guidelines 1
  • The standard pediatric dose of 0.25-0.5 mg (250-500 mcg) applies to children over 2-3 years, but must be reduced by half for toddlers in this age range 1, 2
  • Research from 1987 confirms that for children under 2-3 years, the maximum dose should be 125 mcg delivered as nebulized solution 3

Administration Schedule

  • Give ipratropium every 20 minutes for the first 3 doses as adjunctive therapy to beta-agonists 1, 2
  • After initial 3 doses, continue every 6 hours until improvement begins 1
  • Can be mixed with albuterol in the same nebulizer solution 1, 2

Delivery Technique

  • Must use nebulizer with spacer and face mask for children under 4 years of age 1
  • Use oxygen-driven nebulizer at 6-8 L/min flow rate 1
  • Dilute to minimum of 3 mL total volume for optimal nebulization 1

Albuterol Dosing

Nebulized Albuterol

  • Standard pediatric dosing is weight-based at 0.15 mg/kg per dose 4
  • For a typical 22-month-old (approximately 11-13 kg), this translates to roughly 1.65-1.95 mg per dose
  • Administer every 20 minutes for 3 doses initially, then as needed 1, 2

Combination Product (If Using Pre-Mixed)

  • For children, use 1.5 mL of combination nebulizer solution (containing 0.25 mg ipratropium + 1.25 mg albuterol per 1.5 mL) every 20 minutes for 3 doses, then as needed 1, 2
  • This provides the appropriate half-dose of ipratropium for this age group

Critical Clinical Considerations

When to Add Ipratropium

  • Add ipratropium to albuterol therapy in moderate to severe exacerbations at presentation 1
  • Add if child is not improving after 15-30 minutes of initial beta-agonist therapy 1
  • Add if life-threatening features present (silent chest, cyanosis, altered consciousness) 1

Important Caveats

  • Ipratropium should NOT be used as first-line monotherapy—it must be added to short-acting beta-agonist (SABA) therapy 1, 2
  • May be used for up to 3 hours in initial management of severe exacerbations 1, 2
  • Addition of ipratropium to albuterol has not shown additional benefit once patient is hospitalized 1, 2
  • Always administer systemic corticosteroids (2 mg/kg prednisone/prednisolone) concurrently for acute exacerbations 1, 5

Safety Monitoring

  • Use oxygen-driven nebulizer to maintain oxygen saturation ≥90% 1
  • Monitor for mild anticholinergic effects (dry mouth), though these are typically minimal with inhaled administration 1
  • Heart rate increases are generally mild with combination therapy 4

References

Guideline

Bromuro de Ipratropio Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pediatric Dosage of Ipratropium Bromide (Ipravent)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ipratropium bromide and airways obstruction in childhood.

Postgraduate medical journal, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.